norgestrel has been researched along with 17-alpha-hydroxyprogesterone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acorn, T; Collins, J; Ling, WY; Wilson, E; Wrixon, W | 1 |
Borm, GF; Coenen, CM; Hollanders, JM; Rolland, R; Thomas, CM | 1 |
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T; Zhong, G | 1 |
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T | 1 |
2 trial(s) available for norgestrel and 17-alpha-hydroxyprogesterone
Article | Year |
---|---|
Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Contraceptives, Postcoital; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Luteinizing Hormone; Norgestrel; Ovary; Ovulation; Time Factors | 1983 |
Changes in androgens during treatment with four low-dose contraceptives.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hydroxyprogesterones; Luteal Phase; Norgestrel; Norpregnenes; Pancuronium; Progestins; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1996 |
2 other study(ies) available for norgestrel and 17-alpha-hydroxyprogesterone
Article | Year |
---|---|
Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin.
Topics: 17-alpha-Hydroxyprogesterone; Cell Line, Tumor; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Ethisterone; Female; Humans; Matrix Metalloproteinase 2; Norgestrel; Oximes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2004 |
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured | 2004 |